Immunomodulators and risk for breakthrough COVID-19 after third SARS-CoV-2 mRNA vaccine among patients with rheumatoid arthritis: a cohort study.

Abigail E SchiffXiaosong WangNaomi J PatelYumeko KawanoJennifer L HanbergEmily N KowalskiClaire E CookKathleen Mm VanniGrace QianKatarina J BadeAlene A SaavedraShruthi SrivatsanZachary K WilliamsRathnam K VenkatZachary S WallaceJeffrey A Sparks

Published in: Annals of the rheumatic diseases (2024)

Keyphrases

sars cov
respiratory syndrome coronavirus
coronavirus disease
binding protein